LQDA
LiquidiaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
LQDA vs peer average
71/100
LQDA vs. peer average (A vs. B)
Grade spread
A 1 · B 3 · C 3
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
APLS is the first available peer comparator.
Packet-listed same-sector mid-cap peer candidate; useful as a commercial-stage biotech comp, but not a direct inhaled prostacyclin comparator.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LQDA
Liquidia
APLS
Peer
Grade
A
-
Momentum
97
-
Value
41
-
Sentiment
49
-
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Unrated
Grade position vs APLS
LQDA / APLS
Grade Position
Above peers
LQDA vs. peer average (A vs. B)
71/100
Momentum
97
-Value
41
-Sentiment
49
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LQDA
APLS is the first peer returned for this comparison set.